I saw the company is planning shareholder info sessions in August (Adelaide and Sydney) - an appropriate response to the agitation earlier this year (which, gladly, appears to have quietened down). After the two new Director appointments (and despite Dr Dunton's resignation) the Board appears to have good balance. I am also very pleased to see the CEO is presenting at the Cantor Fitzgerald Healthcare conference in NY. Hopefully we get a bit of a rundown from this at the shareholder sessions. As always GLTAH.
BNO Price at posting:
30.0¢ Sentiment: Hold Disclosure: Held